NCT01181427 - Study of ABT-267 in Both Healthy Volunteers and Hepatitis C Virus (HCV) Genotype 1 Infected Subjects | Biotech Hunter

Enrollment

137

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

March 31, 2011

Study Completion Date

January 31, 2012

Conditions

HCV Infection

Interventions

DRUG

ABT-267

See arm description

DRUG

Placebo

See arms description

PROCEDURE

Blood Sample Collection

See arm description

DRUG

Cytochrome P450 inhibitor

See arm description

Trial Locations (3)

Site Reference ID/Investigator# 42708, Orlando

Site Reference ID/Investigator# 43322, Waukegan

Site Reference ID/Investigator# 42707, San Antonio